Patents Assigned to Hyglos Invest GmbH
-
Publication number: 20140065104Abstract: The present invention relates to a polypeptide termed ply_pitti26 comprising the sequence as depicted in SEQ ID NO:1 as well as variants of this polypeptide. Furthermore, the present invention relates to nucleic acids and vectors encoding for said polypeptide and variants thereof as well as host cells comprising these nucleic acids and/or vectors. Finally, the present invention relates to the uses of said polypeptide, variants thereof, nucleic acid sequences, vectors and host cells, in particular for the treatment or prophylaxis of a subject infected by or exposed to Staphylococci.Type: ApplicationFiled: September 9, 2013Publication date: March 6, 2014Applicant: Hyglos Invest GmbHInventors: Michael FORCHHEIM, Holger GRALLERT, Anja PHILIPP, Manfred BIEBL
-
Publication number: 20130288926Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonisation and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.Type: ApplicationFiled: June 17, 2011Publication date: October 31, 2013Applicant: HYGLOS INVEST GMBHInventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
-
Patent number: 8557519Abstract: The present invention relates to a polypeptide termed ply_pitti26 comprising the sequence as depicted in SEQ ID NO:1 as well as variants of this polypeptide. Furthermore, the present invention relates to nucleic acids and vectors encoding for said polypeptide and variants thereof as well as host cells comprising these nucleic acids and/or vectors. Finally, the present invention relates to the uses of said polypeptide, variants thereof, nucleic acid sequences, vectors and host cells, in particular for the treatment or prophylaxis of a subject infected by or exposed to Staphylococci.Type: GrantFiled: October 19, 2011Date of Patent: October 15, 2013Assignee: Hyglos Invest GmbHInventors: Michael Forchheim, Holger Grallert, Anja Philipp, Manfred Biebl
-
Patent number: 8551719Abstract: The invention relates to a method for detecting endotoxins in a sample.Type: GrantFiled: February 20, 2013Date of Patent: October 8, 2013Assignee: Hyglos Invest GmbHInventors: Roman Meyer, Michael Schütz, Holger Grallert, Renate Grassl, Stefan Miller
-
Publication number: 20130244224Abstract: The invention relates to a method for detecting endotoxins in a sample.Type: ApplicationFiled: February 20, 2013Publication date: September 19, 2013Applicant: HYGLOS INVEST GMBHInventors: Roman MEYER, Michael SCHÜTZ, Holger GRALLERT, Renate GRASSL, Stefan MILLER
-
Patent number: 8492519Abstract: The present invention relates to a modified polypeptide with a biological activity to lyse cell walls of bacteria, wherein the polypeptide has no caspase, clostripain, enterokinase, factor Xa, granzyme B, staphylococcus peptidase I (V8 Protease), plasmin, streptopain, bacillolysin and/or thrombin cleavage site. The invention further relates to nucleic acids with a sequence encoding a polypeptide according to the present invention.Type: GrantFiled: August 19, 2008Date of Patent: July 23, 2013Assignees: Hyglos Invest GmbH, bioMérieux S.A.Inventors: Holger Grallert, Michael Forchheim
-
Publication number: 20130183689Abstract: The present invention relates to bacteriophage tail proteins and the derivatives and fragments thereof that are capable of binding endotoxins in the absence of bivalent positive ions, especially Ca2+ or Mg2+. Further, the present invention relates to methods for depleting endotoxins from solutions and samples using the bacteriophage tail proteins according to the present invention and to a detection method for endotoxins.Type: ApplicationFiled: November 21, 2012Publication date: July 18, 2013Applicant: HYGLOS INVEST GMBHInventor: HYGLOS INVEST GMBH
-
Patent number: 8394597Abstract: The invention relates to a method for detecting endotoxins in a sample.Type: GrantFiled: December 20, 2004Date of Patent: March 12, 2013Assignee: Hyglos Invest GmbHInventors: Roman Meyer, Michael Schütz, Holger Grallert, Renate Grassl, Stefan Miller
-
Patent number: 8329393Abstract: The present invention relates to bacteriophage tail proteins and the derivatives and fragments thereof that are capable of binding endotoxins in the absence of bivalent positive ions, especially Ca2+ or Mg2+. Further, the present invention relates to methods for depleting endotoxins from solutions and samples using the bacteriophage tail proteins according to the present invention and to a detection method for endotoxins.Type: GrantFiled: July 12, 2011Date of Patent: December 11, 2012Assignee: Hyglos Invest GmbHInventors: Stefan Miller, Roman Meyer, Renate Grassl, Manfred Biebl, Holger Grallert
-
Publication number: 20120171188Abstract: The present invention relates to recombinant polypeptides having the activity of binding and lysing of bacteria, comprising at least one enzymatically active domain and at least two bacterial cell binding domains. The present invention further relates to recombinant polypeptide having the activity of binding bacteria, comprising at least two bacterial cell binding domain. Further the present inventions relates to nucleic acid molecules comprising a nucleotide sequence encoding the recombinant polypeptides, vectors and host cells.Type: ApplicationFiled: October 3, 2011Publication date: July 5, 2012Applicants: HYGLOS INVEST GMBH, BIOMERIEUX S.AInventors: Martin Loessner, Mathias Schmelcher, Holger Grallert, Falko Bretfeld
-
Publication number: 20120164126Abstract: The present invention relates to a polypeptide termed ply_pitti26 comprising the sequence as depicted in SEQ ID NO:1 as well as variants of this polypeptide. Furthermore, the present invention relates to nucleic acids and vectors encoding for said polypeptide and variants thereof as well as host cells comprising these nucleic acids and/or vectors. Finally, the present invention relates to the uses of said polypeptide, variants thereof, nucleic acid sequences, vectors and host cells, in particular for the treatment or prophylaxis of a subject infected by or exposed to Staphylococci.Type: ApplicationFiled: October 19, 2011Publication date: June 28, 2012Applicant: HYGLOS INVEST GMBHInventors: Michael Forchheim, Holger Grallert, Anja Philipp, Manfred Biebl
-
Publication number: 20110306068Abstract: The present invention relates to bacteriophage tail proteins and the derivatives and fragments thereof that are capable of binding endotoxins in the absence of bivalent positive ions, especially Ca2+ or Mg2+. Further, the present invention relates to methods for depleting endotoxins from solutions and samples using the bacteriophage tail proteins according to the present invention and to a detection method for endotoxins.Type: ApplicationFiled: July 12, 2011Publication date: December 15, 2011Applicant: HYGLOS INVEST GMBHInventors: Stefan Miller, Roman Meyer, Renate Grassl, Manfred Biebl, Holger Grallert
-
Patent number: 8058225Abstract: The present invention relates to a polypeptide termed ply_pitti26 comprising the sequence as depicted in SEQ ID NO:1 as well as variants of this polypeptide. Furthermore, the present invention relates to nucleic acids and vectors encoding for said polypeptide and variants thereof as well as host cells comprising these nucleic acids and/or vectors. Finally, the present invention relates to the uses of said polypeptide, variants thereof, nucleic acid sequences, vectors and host cells, in particular for the treatment or prophylaxis of a subject infected by or exposed to Staphylococci.Type: GrantFiled: August 19, 2008Date of Patent: November 15, 2011Assignee: Hyglos Invest GmbHInventors: Michael Forchheim, Holger Grallert, Anja Philipp, Manfred Biebl
-
Patent number: 8003313Abstract: The present invention relates to bacteriophage tail proteins and the derivatives and fragments thereof that are capable of binding endotoxins in the absence of bivalent positive ions, especially Ca2+ or Mg2+. Further, the present invention relates to methods for depleting endotoxins from solutions and samples using the bacteriophage tail proteins according to the present invention and to a detection method for endotoxins.Type: GrantFiled: January 23, 2006Date of Patent: August 23, 2011Assignee: Hyglos Invest GmbHInventors: Stefan Miller, Roman Meyer, Renate Grassl, Manfred Biebl, Holger Grallert
-
Publication number: 20110053188Abstract: The invention relates to a method for detecting endotoxins in a sample.Type: ApplicationFiled: December 20, 2004Publication date: March 3, 2011Applicant: HYGLOS INVEST GMBHInventors: Roman Meyer, Michael Schütz, Holger Grallert, Renate Grassl, Stefan Miller
-
Patent number: 7868144Abstract: The present invention relates to a method for unspecific enrichment of bacterial cells by means of cationic or anionic polymers and magnetic carriers.Type: GrantFiled: October 8, 2002Date of Patent: January 11, 2011Assignee: Hyglos Invest GmbHInventors: Sabine Diller, Renate Grassl, Stefan Miller, Ingrid Robl, Michael Schütz, Thomas Zander
-
Patent number: 7858299Abstract: The invention relates to a method for identifying endotoxins for eliminating said endotoxins from a sample, with the aid of bacteriophage tail proteins.Type: GrantFiled: July 28, 2009Date of Patent: December 28, 2010Assignee: Hyglos Invest GmbHInventors: Michael Schütz, Roman Meyer, Holger Grallert, Stefan Miller
-
Publication number: 20100047895Abstract: The present invention relates to a method for the selective purification of bacterial cells and/or cell components, whereby the purification is performed by means of a solid support.Type: ApplicationFiled: July 28, 2009Publication date: February 25, 2010Applicants: Hyglos Invest GmbH, bioMerieux S.A.Inventors: Michael Schütz, Renate Grassl, Roman Meyer, Sibylle Frick, Ingrid Robl, Thomas Zander, Stefan Miller